• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

Sygnature Discovery

February 7, 2019
Pharmaceutical News

Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership to develop first in class therapies

Pathios Therapeutics (“Pathios”), an innovative biotech company focused on the development of first in class therapies for autoimmune diseases and immuno-oncology and Sygnature Discovery (“Sygnature”), jointly announce a strategic partnership to accelerate Pathios’ drug discovery and development programmes. As part of the agreement, Pathios

More
March 25, 2019

Sygnature Discovery Boosts DMPK Capabilities with Four Senior Appointments

Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company,

Sygnature Discovery Develops AR Molecular Visualisation Prototype
September 20, 2019

Sygnature Discovery Develops AR Molecular Visualisation Prototype

The space occupied by a drug molecule in three dimensions, and how

Sygnature Discovery Develops AR Molecular Visualisation Prototype
Pharmaceutical News

Sygnature Discovery Develops AR Molecular Visualisation Prototype

September 20, 2019

The space occupied by a drug molecule in three dimensions, and how it fits into the target, is an important

More
Pharmaceutical News

Sygnature Discovery Boosts DMPK Capabilities with Four Senior Appointments

March 25, 2019

Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, has recruited four key individuals to boost its

More
Pharmaceutical News

Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership to develop first in class therapies

February 7, 2019

Pathios Therapeutics (“Pathios”), an innovative biotech company focused on the development of first in class therapies for autoimmune diseases and

More
  • Croda and Botanical Solution Inc. (BSI) partner to fast-track sustainable vaccine adjuvant QS-21 production
  • Liquid Nitrogen Freezers Prove to be Game Changer for Pharma Industry
  • Breye Therapeutics Strengthens Management Team and Board
  • How Healthcare Professionals Benefit From Field Hospitals
  • Sterling Pharma Solutions Granted MIA (IMP) License by MHRA for cGMP Antibody-Drug Conjugate Manufacturing at its Facility in Deeside, UK

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop